INTERNATIONAL PATENT: FUNDAÇAO OSWALDO CRUZ FILES APPLICATION FOR "MOLECULE OF RECOMBINANT NUCLEIC ACID, EPITOPE OF ALPHA TOXIN OF RECOMBINANT C. NOVYI AND USE THEREOF, EXPRESSION VECTOR, VACCINE COMPOSITION, METHOD FOR PREVENTING OR TREATING CLOSTRIDIOSIS IN AN INDIVIDUAL SUFFERING FROM SAME AND METHOD FOR PRODUCING A VACCINE COMPOSITION AGAINST CLOSTRIDIOSIS"

GENEVA, May 16 -- FUNDAÇAO OSWALDO CRUZ (AV. BRASIL, 4365MANGUINHOS21040360 Rio de Janeiro-RJ) filed a patent application (PCT/BR2024/050509) for "MOLECULE OF RECOMBINANT NUCLEIC ACID, EPITOPE OF ALPHA TOXIN OF RECOMBINANT C. NOVYI AND USE THEREOF, EXPRESSION VECTOR, VACCINE COMPOSITION, METHOD FOR PREVENTING OR TREATING CLOSTRIDIOSIS IN AN INDIVIDUAL SUFFERING FROM SAME AND METHOD FOR PRODUCING A VACCINE COMPOSITION AGAINST CLOSTRIDIOSIS" on Nov 06, 2024. With publication no. WO/2025/097230, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organizatio...